Type your tag names separated by a space and hit enter



Complementary/Alternative Medicine: This monograph describes a natural or herbal product that is not subject to FDA guidelines for medicines. Patients and clinicians are advised to read package labels carefully to ensure safe and efficacious use.


Trade Name(s)

  • yohimbe bark
  • Pausinystalia yohimbe
  • Corynanthe johimbi

Ther. Class.
erectile dysfunction agents

Common Uses

Sexual dysfunction.


Yohimbine causes genital blood vessel dilation, nerve impulse transmission to genital tissue, and increased reflex excitability in the sacral region of the spinal cord. It works primarily through alpha 2–adrenergic receptor blockade and also has monoamine oxidase inhibiting, calcium channel blocking, and serotonin receptor blocking effects.

Therapeutic Effect(s):

Improved sexual function.


Absorption: Unknown

Distribution: Unknown

Metabolism and Excretion: Unknown

Half-life: Unknown




Contraindicated in:

  • Hypersensitivity.
  • Angina.
  • Anxiety and depression.
  • Hypotension.
  • Heart disease.
  • Kidney disease.
  • Liver disease.
  • Pregnancy and lactation.
  • Children.

Use Cautiously in:

  • Benign prostatic hyperplasia.
  • Diabetes.
  • Hypertension.
  • Post-traumatic stress disorder.
  • Schizophrenia.
  • Concomitant use with consumption of tyramine-containing foods can lead to hypertensive crisis.
  • Excessive doses without medical supervision can cause significant toxicity.

Adverse Reactions/Side Effects

CV: hypertension, tachycardia, cardiac failure (high doses)

CNS: excitation, headache, tremor, anxiety, dizziness, insomnia

Derm: rash

F and E: fluid retention

GI: nausea, vomiting

GU: urinary frequency

MS: paralysis (high doses)

Misc: hypersensitivity reactions

Resp: respiratory depression (high doses)

* CAPITALS indicate life-threatening.
Underline indicate most frequent.


Natural Drug Interaction

  • Additive effects with monoamine oxidase inhibitors..
  • Antagonistic effects with clonidine and other antihypertensives.
  • Increased risk of alpha 2–adrenergic antagonism with phenothiazines..Increased risk of hypertensive crisis with stimulants..
  • May increase or decrease BP with tricyclic antidepressants..


Concomitant use with caffeine-containing herbsand ephedra can cause hypertensive crisis.


PO: (Adults) 15–30 mg/daily. Doses up to 100 mg/day have been used but with significantly more side effects.


Capsules: 2.5 mg, 3 mg


  • Assess frequency and severity of erectile dysfunction.

Potential Diagnoses

  • Sexual dysfunction (Indications)


  • PO: May increase bioavailability by taking on an empty stomach.

Patient/Family Teaching

  • Instruct patient to take as recommended.
  • Advise patient to notify health care professional of all Rx or OTC medications, vitamins, or herbal products being taken and to consult with health care professional before taking other medications, especially stimulants.
  • Advise female patient to notify health care professional if pregnancy is planned or suspected or if breastfeeding.

Evaluation/Desired Outcomes

Male erection sufficient to allow intercourse.

yohimbine is a sample topic from the Davis's Drug Guide.

To view other topics, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Learn more.


Quiring, Courtney, et al. "Yohimbine." Davis's Drug Guide, 16th ed., F.A. Davis Company, 2019. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110141/all/yohimbine.
Quiring C, Sanoski CA, Vallerand AH. Yohimbine. Davis's Drug Guide. 16th ed. F.A. Davis Company; 2019. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110141/all/yohimbine. Accessed April 26, 2019.
Quiring, C., Sanoski, C. A., & Vallerand, A. H. (2019). Yohimbine. In Davis's Drug Guide. Available from https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110141/all/yohimbine
Quiring C, Sanoski CA, Vallerand AH. Yohimbine [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2019. [cited 2019 April 26]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110141/all/yohimbine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - yohimbine ID - 110141 A1 - Quiring,Courtney, AU - Sanoski,Cynthia A, AU - Vallerand,April Hazard, BT - Davis's Drug Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110141/all/yohimbine PB - F.A. Davis Company ET - 16 DB - Pediatrics Central DP - Unbound Medicine ER -